Open access · CC-BY
via OpenAlex
Strategies for in vivo reprogramming
Andreas Ofenbauer, Baris Tursun
Current Opinion in Cell Biology · 2019 · ▲ 25 citations
Abstract
Reprogramming has the potential to provide specific cell types for regenerative medicine applications aiming at replacing tissues that have been lost or damaged due to degenerative diseases and injury. In this review we discuss the latest strategies and advances of in vivo reprogramming to convert cell identities in living organisms, including reprogramming induced by transcription factors (TFs) and CRISPR/dCas9 synthetic TFs, as well as by cell fusion and small molecules. We also provide a brief recap of reprogramming barriers, the effect of senescence(definition) on reprogramming efficiency, and strategies to deliver reprogramming factors in vivo. Because of the limited space, we omit dwelling on naturally occurring reprogramming phenomena such as developmentally programmed transdifferentiation found in the nematode Caenorhabditis elegans.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.ceb.2019.06.002
- Canonical
- link ↗
- Fetched
- 2026-08-03 MST
Cite this
APA
Ofenbauer, A., & Tursun, B. (2019). Strategies for in vivo reprogramming. <em>Current Opinion in Cell Biology</em>. https://doi.org/10.1016/j.ceb.2019.06.002
Vancouver
Ofenbauer A, Tursun B. Strategies for in vivo reprogramming. Current Opinion in Cell Biology. 2019. doi:10.1016/j.ceb.2019.06.002.
BibTeX
@article{andreas2019Strate,
title = {Strategies for in vivo reprogramming},
author = {Andreas Ofenbauer and Baris Tursun},
journal = {Current Opinion in Cell Biology},
year = {2019},
doi = {10.1016/j.ceb.2019.06.002},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Advanced Drug Delivery Reviews 2021
Preprint · OA
mRNA – A game changer in regenerative medicine, cell-based therapy and reprogramming strategies
Communications Biology 2024
Open access · CC-BY
In vivo cyclic overexpression of Yamanaka factors restricted to neurons reverses age-associated phenotypes and enhances memory performance
Trends in Cell Biology 2023
Open access · CC-BY
Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective
Stem Cells 2018
Open access · OA
Reduction of Fibrosis and Scar Formation by Partial Reprogramming In Vivo
Aging cell 2026
Open access · OA
In Vivo Partial Cell Reprogramming With Yamanaka Factors Reduced Ischemic Brain Damage in Aging Mice
Nutrients 2016
Open access · CC-BY